title: [Clinical basis of provocative detoxicating etiotropic therapy of chronic toxoplasmosis in pediatric cases].
abstract: Clinical and laboratory data on the treatment of 19 children with chronic toxoplasmosis were used for estimation of the efficacy of drug combination, such as spiramycin + lidase and lincomycin + lidase vs. the traditional therapy (co-trimoxazole, metronidazole). The combination designed by us, i.e. spiramycin + lidase, lincomycin + lidase used in consecutive courses proved to be more efficient.
authors.forename: I P
authors.initials: IP
authors.lastname: Kulmagambetov
authors.forename: I V
authors.initials: IV
authors.lastname: Timofeev
authors.forename: R Kh
authors.initials: RKh
authors.lastname: Begaĭdarova
authors.forename: T A
authors.initials: TA
authors.lastname: Konstantinidi
authors.forename: E S
authors.initials: ES
authors.lastname: Perevertova
mesh_terms: D000284:Administration, Oral; D002648:Child; D002908:Chronic Disease; D003049:Coccidiostats / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000008:administration & dosage / Q000627:therapeutic use*; D007273:Injections, Intramuscular; D008034:Lincomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D015572:Spiramycin / Q000008:administration & dosage / Q000627:therapeutic use*; D014123:Toxoplasmosis / Q000188:drug therapy*
chemical_list: D003049:Coccidiostats; D015572:Spiramycin; D008034:Lincomycin; C001543:lidase; D006821:Hyaluronoglucosaminidase